Diabetes Center at UCSF
A History of Innovation, a Vision of a Cure
Founded in 2000, Diabetes Center at UCSF is an integrated team of researchers and physicians in fields of cell development, endocrinology and metabolism, and immunology.
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs, M. Anderson et al
Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy, M. Anderson et al.
ASB4 modulates central melanocortinergic neurons and calcitonin signaling to control satiety and glucose homeostasis, A. Xu et al
Nature Experimental & Molecular Medicine
Metabolic factors in the regulation of hypothalamic innate immune responses in obesity, S. Koliwad et al
Featured News & Media
Dr. Gerold Morton Grodsky (Professor of Biochemistry & Biophysics and Medicine, UCSF, Emeritus, Active), science professor and bon vivant, who...
US Food and Drug Administration (FDA) approved the use of Teplizumab under the brand name Tzield, an immunotherapy drug, which has been shown to significantly delay the onset of type 1 diabetes. This...
Thursday November 3, 2022 9:00a-5:00p Join us to celebrate the 20th anniversary of the UCSF Diabetes Center. Hear from our distinguished researchers who will share updates on their groundbreaking...
Last year the World Health Organization (WHO) launched the NCD LAB, an initiative leveraging community-driven grassroots innovations with the potential to be game changers in beating non-communicable...